Cargando…

Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis

BACKGROUND: To allow early diagnosis and monitoring of disease progression, there is a need for biomarkers in amyotrophic lateral sclerosis (ALS). Neurofilaments (NF) are emerging protein biomarkers in other neurological diseases, and are of possible use in ALS. OBJECTIVE: The aim of this study is t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Zhouwei, Henderson, Robert David, David, Michael, McCombe, Pamela Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061412/ https://www.ncbi.nlm.nih.gov/pubmed/27732645 http://dx.doi.org/10.1371/journal.pone.0164625

Ejemplares similares

Age of Onset and Length of Survival of Queensland Patients with Amyotrophic Lateral Sclerosis: Details of Subjects with Early Onset and Subjects with Long Survival
por: Nona, Robert J., et al.
Publicado: (2023)

The Peripheral Immune System and Amyotrophic Lateral Sclerosis
por: McCombe, Pamela A., et al.
Publicado: (2020)

Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis
por: Devine, Matthew S., et al.
Publicado: (2015)

Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions
por: Ngo, Shyuan T, et al.
Publicado: (2017)

Monocytes and neutrophils are associated with clinical features in amyotrophic lateral sclerosis
por: McGill, Raquel B, et al.
Publicado: (2020)

Tract integrity in amyotrophic lateral sclerosis: 6–month evaluation using MR diffusion tensor imaging
por: Alruwaili, Ashwag R., et al.
Publicado: (2019)

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
por: Lu, Ching-Hua, et al.
Publicado: (2015)

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

Serial MRI studies over 12 months using manual and atlas-based region of interest in patients with amyotrophic lateral sclerosis
por: Alruwaili, Ashwag R., et al.
Publicado: (2020)

Role of Blood Neurofilaments in the Prognosis of Amyotrophic Lateral Sclerosis: A Meta-Analysis
por: Zhou, Yan-ni, et al.
Publicado: (2021)

Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain
por: Thompson, Alexander G., et al.
Publicado: (2022)

Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
por: Falzone, Yuri Matteo, et al.
Publicado: (2021)

Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis
por: De Schaepdryver, Maxim, et al.
Publicado: (2022)

Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis
por: Chang, Jeryn, et al.
Publicado: (2022)

Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
por: Shi, Jiaying, et al.
Publicado: (2021)

Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort
por: Talman, Paul, et al.
Publicado: (2016)

Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis
por: Henderson, Robert D., et al.
Publicado: (2021)

Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
por: Verde, Federico, et al.
Publicado: (2023)

Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis
por: Davies, Jennifer C, et al.
Publicado: (2023)

Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal
por: Benatar, Michael, et al.
Publicado: (2022)

Longitudinal biomarkers in amyotrophic lateral sclerosis
por: Huang, Fen, et al.
Publicado: (2020)

Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosis
por: Masrori, Pegah, et al.
Publicado: (2022)

Altered skeletal muscle glucose–fatty acid flux in amyotrophic lateral sclerosis
por: Steyn, Frederik J, et al.
Publicado: (2020)

Diagnostic Performance of Neurofilaments in Chinese Patients With Amyotrophic Lateral Sclerosis: A Prospective Study
por: Li, Da-Wei, et al.
Publicado: (2018)

Systematic Review and Meta-Analyses of Aminopeptidases as Prognostic Biomarkers in Amyotrophic Lateral Sclerosis
por: Teruel-Peña, Bárbara, et al.
Publicado: (2023)

Role of plasma phosphorylated neurofilament heavy chain (pNfH) in amyotrophic lateral sclerosis
por: Zecca, Chiara, et al.
Publicado: (2022)

Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
por: Kirk, Siobhan E., et al.
Publicado: (2019)

Functional Biomarkers for Amyotrophic Lateral Sclerosis
por: Huynh, William, et al.
Publicado: (2019)

Lipid Biomarkers for Amyotrophic Lateral Sclerosis
por: González De Aguilar, Jose-Luis
Publicado: (2019)

Smads as muscle biomarkers in amyotrophic lateral sclerosis
por: Si, Ying, et al.
Publicado: (2014)

Whole exome sequencing and DNA methylation analysis in a clinical amyotrophic lateral sclerosis cohort
por: Garton, Fleur C., et al.
Publicado: (2017)

Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis
por: Wilson, Meghan E., et al.
Publicado: (2010)

The Short and Long-Term Effects of Pregnancy on Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: McCombe, Pamela A
Publicado: (2018)

Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis
por: Staats, Kim A., et al.
Publicado: (2022)

Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study
por: Vacchiano, Veria, et al.
Publicado: (2021)

Neurofilament accumulations in amyotrophic lateral sclerosis patients’ motor neurons impair axonal initial segment integrity
por: Lefebvre-Omar, Cynthia, et al.
Publicado: (2023)

The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis
por: Forgrave, Lauren M., et al.
Publicado: (2019)

MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis
por: Ricci, Claudia, et al.
Publicado: (2018)

Biomarkers and molecular mechanisms of Amyotrophic Lateral Sclerosis
por: Chakraborty, Ashok, et al.
Publicado: (2022)

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4kdgtkuijmm9i456vtij8jl3dk